1Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc N Y Pathol Soc 1924;24 :21-24.
2Loirat C, Veyradier A, Girma JP, Ribba AS, Meyer D. Thrombotic thrombocytopenic purpura associated with yon Willebrand factor --cleaving protease (ADAMTS13) deficiency in children. Semin Thromb Hemost. 2006 Mart32(2) :90-97.
3Morrin MJ, Jones FG, McConville J, et al. Thrombotic thromboeytopenic purpura secondary to Streptococcus. Transfus Apher Sci,2006,34(2):153-155.
4Rivkin A. Thrombotic thrombocytopenic purpura induced by metronidazole vaginal gel. Pharmacotherapy 2007 Jul; 27 (7) : 1058- 1061.
5Robertson C, Wiselka MJ. Thrombotic thrombocytopaenic purpura occurring in consecutive pregnancies in an HIV-infected patient. Int J STD AIDS. 2007 Feb;18(2) : 142-143.
6Carr DJ, Kramer BS, Dragonetti DE. Thrombotic thrombocytopenic purpura associated with metastatic gastric adenocarcinorna: successful management with plasmapheresis. South Med J. 1986;79(4):476-479.
7Tsai HM. Current concepts in thrombotic thrombocytopenic purpura. Annu Rev Med. 2006;57:419-436.
8Shelat SG, Smith P, Ai J, et al. Inhibitory autoantibodies against ADAMTS--13 in patients with thrombotic thromboeytopenic purpura bind ADAMTS-- 13 protease and may accelerate its clearance in vivo. J Thromb Haemost. 2006,4(8):1707-1717.
9Mannucci PM. Thrombotic thromboytopenic purpura: another example of immunomediated thrombosis. Pathophysiol Haemost Thromb. 2006; 35(1-2) :89-97.